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Abstract 
Depression and anxiety are common and debilitating illnesses that negatively impact personal 
well-being and functioning. The effects of depression and anxiety not only affect the individual, 
but also peers, family, the community, economy, and even the health care system. 
Pharmacological therapy is a first line treatment for depression and anxiety, but the risk for 
relapse remains. Cognitive behavioral therapy (CBT) and mindfulness-based cognitive therapy 
(MBCT) are treatments that have demonstrated effectiveness in treating depression. The 
evidence suggests that both therapies are successful in terms of reducing depressive symptoms, 
but most effective when combined. Further, evidence shows that the combination of MBCT and 
traditional pharmacological therapy provides relief from depressive symptoms and lengthens the 
amount of time between recurrent episodes and improves the quality of life. A project was 
implemented at an integrated health clinic to evaluate the effectiveness of a mindfulness-based 
intervention to reduce the symptoms of depression and anxiety. The results revealed that 
practicing mindfulness was statistically and clinically significant in reducing depression and 
anxiety. In addition, mindfulness scores increased over 30 day application of the intervention. 
The results demonstrated the value of utilizing mindfulness as a cost-effective therapy in 
addition to pharmacological treatment to decrease symptoms of depression and anxiety, as well 
as improve mindfulness. The ease of use demonstrated the value of mindfulness and self-directed 
skills aimed at improving wellness, reducing depression and anxiety which will result in the 
improvement of individual, economic, healthcare system, and community health. 
  
 Keywords:  depression, mindfulness-based cognitive therapy, cognitive behavioral 
therapy, resilience, treatment, effectiveness, pharmacotherapy 
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The Effects of Mindfulness on Depression and Anxiety 
 Major depression is one of the most common mental illnesses characterized by persistent 
sadness, emptiness, decreased concentration, weight changes, sleep changes, or irritable mood, 
which can significantly impair the individual’s ability to function. According to the Diagnostic 
and Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association 
[APA], 2013), depressive disorders include disruptive mood dysregulation disorder, major 
depressive disorder, persistent depressive disorder, premenstrual dysphoric disorder, substance or 
medication induced depressive disorder as well as other depressive disorder due to a medical 
condition or unspecified.  One of the primary treatments for depression consists of 
pharmacological therapy; however, other interventions can be applied in conjunction with 
medication to treat this debilitating illness. Cognitive behavioral therapy (CBT) is one of many 
interventions currently used to treat depression (APA, 2006). Anxiety is the most common 
mental illness characterized by excessive worry about a variety of events more days than not. 
Key symptoms include restlessness, irritability, and decreased sleep. Anxiety disorders can also 
interfere with relationships as well as work or school performance (NIMH, 2017). Treatments for 
depression consist of first line pharmacological treatment, but also can include different forms of 
therapies.  
Problem Statement 
According to the Centers for Disease Control and Prevention (CDC, 2016), the economic 
burden of depression was estimated to be $210.5 billion in 2010. Anxiety is associated with 
economic costs due to lost work productivity and high medical resource use. Depressive episodes 
are noted as a risk factor for suicide. Suicide is the fourth leading cause of death among adults 
age 18 to 65 years of age. Patients at risk for suicide include not only patients currently in crisis, 
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but also those who have an existing diagnosis of depression, bipolar disorder, schizophrenia, or 
substance abuse disorder (Norris & Clark, 2012).  According to Healthy People 2020 (2014), 
11.3 suicides per 100,000 people occurred in 2007.  The target is a 10% reduction in suicide rates 
to 10.2 suicides per 100,000 people by 2020. 
Another goal by Healthy People 2020 (2014) is to reduce the proportion of adults ages 18 
years or older who experience a major depressive episode. In the United States, an estimated 
6.5% of adults ages 18 years or older suffered a depressive episode. The goal is to reduce this by 
10% in 2020, for a target of 5.8%. CBT is an important intervention that can reduce the 
occurrence of relapse in a depressive episode and work towards the health initiative to improve 
depression and suicide rates (Butler, Chapman, Forman, & Beck, 2006; Freeman & Freeman, 
2005).  
Background and Clinical Significance 
Depression bears a direct ability to influence the daily quality of life. According to the 
National Institute of Mental Health (NIMH, 2017), 6.7%, roughly 16.2 million adults in the 
United States had at least one major depressive episode. NIMH also found that 19.1% of US 
adults had any anxiety disorder in the past year, with 2.7% of adults in the US diagnosed with 
generalized anxiety. Depression is associated with increased healthcare needs, absenteeism from 
school and work, as well as increased mortality. It is estimated that it will be the second-leading 
cause of disability worldwide by 2020 (Lutz, Schiefele, Wucherpfennig, Rubel, & Stulz 2016). 
Depression is significant for its comorbidity with smoking, alcohol consumption, sleep 
disturbances, heart disease, obesity, and physical inactivity, as well as other psychiatric 
conditions such as anxiety or substance abuse (APA, 2013). According to the CDC (2016), 1 out 
of 20 Americans age 12 years and older reported current depression. This is significant, because 
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if an episode of depression is not treated effectively, there is a 50% risk of recurrence of 
depression. The landmark study by the National Institute of Mental Health, Sequenced Treatment 
Alternatives to Relieve Depression, showed remission in only one third of major depression 
patients after first anti-depressant trial and lower response rates with each subsequent trial 
(Eisendrath et al., 2014). Evidence shows that medication is better than placebo in reducing the 
risk of relapse; however adherence to treatment continues to be a problem, and the effectiveness 
of medication decreases as number of previous episodes increases (Huijbers, Spinhoven, van 
Schaik, Nolen, & Speckens, 2016; Kuyken et al., 2015; Shallcross et al., 2015).  Although anti-
depressant therapy is considered a first-line treatment for depression, evidence shows 
interventions such as CBT and MBCT are effective methods for reducing depressive symptoms 
(Chiesa et al., 2012; Lenz, Hall, & Bailey Smith, 2016).    
CBT is a therapy that focuses on understanding the link between thoughts, feelings, and 
behaviors. A goal of CBT is to identify and modify destructive or negative thinking patterns, 
assumptions about self, and the world. CBT is recognized as a first treatment of choice for 
patients who need to improve internal resources and coping skills (Wheeler, 2014). The CBT 
model can be associated with the Roy Adaptation Model (Freeman, 2005). The Roy Adaptation 
Model is applicable to a person diagnosed with depression precisely because it focuses on the 
interaction that nursing has to help the individual achieve optimal health by adapting in the areas 
of biological, psychological, emotional, and psychosocial, well-being (Freeman, 2005). CBT as 
an intervention is relevant to the Roy Adaptation Model because through taking care of the 
psychological and emotional aspects, improvement will be seen in psychosocial functioning and 
biological well-being.  
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Shinohara et al. (2013) completed a systematic review of multiple randomized controlled 
trials targeting treatment of acute depression in adults. The data suggested that participants 
responded better to cognitive behavioral based therapies than to other therapies with minimized 
risk. The study suggests that there is a reduction in risk to increasing depression by 7%. CBT 
was equally effective to anti-depressant treatment in adult depression (Butler et al., 2006; 
Meuldijk et al., 2016). The meta-analysis completed by Butler, Chapman, Forman and Beck 
(2006) also found that the relapse rate for depression when receiving CBT was 29.5% compared 
to 60% of individuals being treated with medication alone. Not only is CBT effective, but also 
has longer lasting periods before next recurrence or exacerbation of symptoms. Interestingly the 
effects of therapy versus medication were longer lasting for the therapy group at the 12 month 
period following any type of intervention (Butler et al., 2006; DeRubeis et al., 2005). The key to 
intervention and treatment for depression is that there is not only one intervention that works, but 
that rather a multi-faceted approach must be taken to help subside the symptoms of depression. 
Combination therapy of both cognitive therapy and antidepressants enhances the rate of recovery 
for depression (Hollon et al, 2015; Meuldijk et al., 2016).  
A potential barrier to these interventions is that intervention is implemented over a course 
of several months and as a result, both the patient and economy suffer greater costs (Kuyken et 
al., 2015). There is an identified need to evaluate not only the effectiveness of CBT, but also to 
find methods to obtain the greatest impact for positive outcomes in a more rapid timeline. 
Concise versions of CBT with or without pharmacological interventions were as effective and 
may also yield quicker results (Lutz et al., 2016; Meuldijk et al., 2016). 
CBT therapy has shown to be particularly efficacious in increased prolongation of 
recurrence of symptoms and has been the basis of further interventions (DeRubeis et al. 2005; 
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Lutz et al., 2016). MBCT is a group-based, 8 week, mind-body intervention integrating 
mindfulness meditation with concepts of CBT and was specifically developed as a relapse 
prevention intervention for depression (Eisendrath et al., 2015; Omidi, Mohammadkhani, 
Mohammadi, & Zargar, 2013).  MBCT is designed to teach patients skills that allow them to 
become more aware of thoughts, feelings, bodily sensations, and how they relate to them. The 
goal is to incorporate those skills to modify automatic dysfunctional cognitive perceptions and 
thereby reduce risk of relapse and recurrence of depression (Chiesa, Mandelli, & Serretti, 2012). 
When compared to psychoeducation, MBCT was more effective at reducing depressive 
symptoms for those who did not achieve full remission with pharmacotherapy alone (Chiesa et 
al., 2012; Lenz, Hall, & Bailey Smith, 2016). MBCT was more effective and cost-effective than 
antidepressant treatment alone in mitigating depressive symptoms and undergoing relapse 
(Eisendrath et al., 2015; Kuyken et al., 2015; Omidi et al., 2013). Further, evidence shows that 
the combination of MBCT and traditional pharmacological therapy provides relief from 
depressive symptoms and lengthens the amount of time between recurrent episodes and improves 
the quality of life (Chiesa, Mandelli, & Serretti, 2012; Eisendrath et al., 2015; Kuyken et al., 
2015; Lenz, Hall, & Bailey Smith, 2016; Meuldijk et al., 2016; Omidi, Mohammadkhani, 
Mohammadi, & Zargar, 2013). 
The issue of preference for treatment arose as to whether treatment preference had any 
type of impact on effect. Huijbers, Spinhoven, van Schaik, Nolen, and Speckens (2016) further 
found that those with a preference for medication did equally well as those that had a preference 
for mindfulness. Further landmark studies have examined the use of MBCT as an augmentation 
treatment for depression showing statistically significant effect sizes of d = 1 (Eisendrath et al., 
2015). These results indicate that mindfulness is effective as a treatment for depression. 
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Internal Evidence 
The evidence collected highlights the significance and impact depression has on 
individual and community wellness. The vested stakeholders affected by this issue are primarily 
the patients seeking treatment for depression, healthcare practitioners, healthcare system, and the 
population as a whole. In the southwestern United States, an outpatient integrated health facility 
not only focuses on mental health treatment but also addresses physical well-being as part of an 
integrative care approach. Currently, patients diagnosed with depression or anxiety are not 
pursuing any additional non-pharmacological treatment to aid in treatment and relapse 
prevention of depression according to observation, patient self report, and current prescribers. 
Although groups are offered at the site, patients either do not wish to engage in groups or 
indicate an interest in receiving only medication at the time of appointment, at times citing time 
constraints as a barrier. Patients also report that sometimes they may be affected by their 
symptoms – a person suffering from depression may not have the energy or motivation to attend 
group or a person diagnosed with anxiety may not be comfortable in a group setting or be too 
preoccupied and restless to sit through a session. A psychiatric nurse practitioner supervisor has 
been identified as a champion of utilizing sustainable, non-pharmacological interventions to 
decrease the effects of depression and anxiety. Similarly, the site can receive additional state 
funding for good treatment outcomes. The community and population as a whole will benefit 
from patients with a reduction in depression.  
The clinical significance of depression and anxiety led to the formulation of the clinically 
relevant PICOT question, “In adults diagnosed with depression and anxiety, how does a 
mindfulness-based intervention compared to usual care affect depression scores in a two month 
period?” 
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Search Strategy 
 The PICOT question guided the search for relevant sources and latest evidence-based 
practice. Multiple databases were searched including The Cochrane Library, Academic Search 
Premiere, Cumulative Index of Nursing and Allied Health Literature (CINAHL), PsychInfo, 
PsycArticles, and PubMed. The initial search in Cochrane Library yielded 9740 results 
(Appendix A) with a final yield of 52 when search narrowed to include English language only, 
results in the past five years, and focusing on the combination of key terms depression, 
mindfulness, cognitive behavioral therapy, effectiveness and therapy. Academic Search Premiere 
Database yielded 5804 results upon initial search (Appendix B) and yielded an end result of 19 
with combination of key terms depression, mindfulness, cognitive behavioral therapy, 
effectiveness, randomized control, and pharmacotherapy. Initial search in CINAHL (Appendix 
C) yielded 3800 results with a final yield of five with combination of terms and inclusion of peer 
reviewed and English language studies only. The PsychInfo, PubMed, Psycharticles, 
ScienceDirect, JSTOR, and BioMed Central databases were searched utilizing the terms 
depression, cognitive behavioral therapy, mindfulness, effectiveness, treatment, medication, 
pharmacotherapy, and randomized control trial. The final yield in PsychInfo database yielded 
four significant results (Appendix D). The final yields included 46 results from PubMed 
(Appendix E), 53 from Psycharticles (Appendix F), 66 from ScienceDirect (Appendix G), 13 
from JSTOR (Appendix H), and 131 from BioMed Central (Appendix I). Applying the process 
of rapid critical appraisal (Melnyk & Fineout-Overholt, 2015), 13 of the most clinically relevant 
articles were included in this review (Appendix J). 
Critical Appraisal and Synthesis 
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 The evidence found supporting the use of MBCT and CBT in treatment of depression 
was robust and included thirteen articles (Appendix K). All of articles with the exception of one 
sustained were high level evidence ranked on Level I or Level II hierarchy of evidence (Melnyk 
& Fineout-Overholt, 2015). The remaining article was a Level III hierarchy of evidence due to 
being a non-randomized controlled trial. Eleven of 13 studies were published within the last five 
years and peer reviewed with the exclusion of landmark systematic reviews (Appendix J).  
 The majority of the interventions occurred in outpatient psychiatric treatments. The 
population studies adults diagnosed with any of the subsets of major depression (Appendix J). 
Treatment groups were separated into receiving cognitive therapy with pharmacological 
treatment versus pharmacological treatment only or other therapy (Appendix K).  
 The average length of time for the intervention was eight weeks, with follow up in the 
form of measurement tools assessed for six months (Appendix K), although one study evaluated 
effects over 60 months (Shallcross et al., 2015).  
 The outcomes of interest most frequently examined included the severity of depression, 
recurrence rate, and relapse rate after treatment with intervention (Appendix K). Outcomes were 
measured utilizing valid and reliable instruments, predominantly the Beck Depression Inventory, 
and Hamilton Depression Rating Scale as well as Quality of Life measurements (Appendix J). 
The evidence suggested that utilization of MBCT or CBT resulted in improved depression rating 
scores and had a longer lasting effect in terms of preventing relapse of recurring episode of 
depression (Appendix K). The data does not conclusively suggest a more efficient therapy in 
terms of comparing cognitive therapy with antidepressant treatment; however, the data suggests 
that they are equally effective and beneficial when combined. Three high level studies indicated 
that quality of life is increased significantly with the application of mindfulness-based therapy 
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(Appendix K). The data supports the conclusion that there is no risk with the incorporation of 
cognitive therapy as an intervention. 
 Homogeneity across outcome measures is determined by utilizing standardized rating 
tools as well as establishing baseline diagnoses that are determined to be appropriate with 
research. Potential bias is identified in the Kuyken et al. (2015) study (Appendix J) related to the 
authors being co-directors of a mindfulness society.   
Conclusions of Evidence 
 The utilization of MBCT as an intervention to treat adults diagnosed with depression 
demonstrated improvement in depression rating scores and improved wellness. A significant 
finding is that the combination of MBCT with already existing pharmacotherapy is a powerful 
combination that not only demonstrates improvement of symptoms but also extends the length of 
time between recurrent episodes. The skills obtained during the treatment phase can be learned 
and applied by the individual long after culmination of the intervention. A more important facet 
of this intervention is that there is no risk associated with its implementation. This intervention 
can show evidence to not only be cost-effective but also efficient in decreasing the effects of 
depression, anxiety, and improving general wellness outcomes. The effect of this intervention 
can be profoundly beneficial not only for the individual but also for the health of the population, 
economy, and healthcare system.  
Purpose Statement 
 The purpose of this project was to evaluate the effectiveness of a mindfulness-based 
intervention to reduce the symptoms of depression and anxiety. 
Contribution of Theory to Utility of Evidence 
EFFECTS OF MINDFULNESS ON DEPRESSION AND ANXIETY 12  
 
 The evidence suggests that an intervention involving cognitive therapy can significantly 
improve health in relation to depression. The application of evidence can be best supported by 
adopting a conceptual framework. Pender’s health promotion model (Appendix L) was selected 
as the framework which best describes the purpose of this project. The health promotion model is 
a middle-range theory that highlights the various dimensions of persons interacting with their 
interpersonal and cognitive environments in the search for improved health while integrating 
principles from expectancy value theory and social cognitive theory (Butts & Rich, 2015). This 
model focuses on the experiences and characteristics of the individual, behavior-specific 
cognitions, affect, and behavioral outcomes. One of the most important and applicable 
propositions of the model is that individuals can modify their cognitions to create incentives for 
health actions (Butts & Rich, 2015).  
Evidence Based Practice Model  
 Application and implementation of a project into practice is strengthened not only by a 
strong conceptual framework but also by a model which can guide the application of the 
evidence into practice. The ACE Star Model (Appendix M) was created by the Academic Center 
for Evidence-Based Practice (ACE) at the University of Texas Health Science Center. This 
model focuses on knowledge transformation, which is defined as the conversion of research 
findings to create an impact on health outcomes through evidence-based action (Melnyk & 
Fineout-Overholt, 2015). The model highlights the use of the highest level of evidence and 
summarizing the information to form clinical guidelines while taking theory into account. 
Further guidelines are integrated with individual and organizational actions, which in this project 
include not only the nurse practitioner student but also champions at the clinical site. An 
important part of this model focuses on integrating patient preference into implementation as 
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well as continuous evaluation of health outcomes, economic outcomes, and policy (Melnyk & 
Fineout-Overholt, 2015).  
 In this project, the clinically burning question has led the search for evidence. The 
evidence has been searched systematically and only the best evidence has been selected utilizing 
rapid critical appraisal. The data findings have been summarized to arrive to conclusion, in this 
case, that MBCT is beneficial to improving health outcome for those diagnosed with depression. 
The translation into guideline is then crucial, especially as the information is disseminated to 
champions of the project taking the stakeholders preferences into consideration. Once the 
intervention is applied, it is important to be able to maintain an evaluation through appropriate 
measurement tools to be able to measure impact as well as to be able to modify implementation 
in order to improve sustainability and effects.  
 The evidence reveals that depression continues to be clinically significant issue affecting 
many people. The body of evidence suggests that current first line treatment of medication is 
useful; however, further therapies are important to help reduce incidence and prevent recurrence. 
MBCT has been shown to be efficient in ameliorating the effects of depression alone; however, 
the value in this intervention is its use in conjunction with first line treatment. The 
implementation of the evidence utilizing the ACE Star model and supported through Pender’s 
Health Promotion Model will guide the project to be able to significantly impact the health 
outcomes of people suffering through depression and anxiety while improving population health 
and reducing healthcare cost. 
Application of Evidence to Practice 
 The evidence suggests MBCT is a powerful adjunct to traditional pharmacological 
therapy in the treatment of depression. Implementation of mindfulness can have beneficial 
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effects on improved quality of life and reduction of depressive symptoms. A pilot program was 
implemented at an outpatient integrated health clinic in southwestern Arizona over a three month 
period. The key stakeholders include the patients, nurse practitioners, physician assistant, and 
clinic. Information on most current evidence was presented at quarterly provider meetings to 
disseminate the importance of depression, anxiety, and an effective intervention that may be 
sustainable and cost-effective while improving patient outcomes. A champion of change was 
identified and relied on to help support innovation and became a liaison to the application of new 
knowledge to impact the clinical practice.  
Project Methods 
Participants 
Adults diagnosed with depression and anxiety at an integrated health outpatient clinic in the 
Southwestern United States were invited to participate in a self-directed mindfulness intervention 
spanning 60 days. The proposed timeline of the project was modified to improve participation. 
Inclusion criteria for participation included being English speaking and having access to the 
internet. Participants excluded were those experiencing psychosis or having co-occurring 
substance abuse. Participation was voluntary and participants were allowed to withdraw at any 
time without consequence. Participants signed consents compliant with clinical site HIPAA 
policy and procedure as agreed upon through the clinical site Consent For Evaluation and/or 
Treatment and to Use & Disclose Health Information document. Participants were informed that 
the data collected would be accessed by the primary researcher, ASU faculty mentor, and any 
results obtained from data may be presented during presentations at conferences or publications 
in journal articles. No personal identifying information was released; confidentiality was ensured 
by assigning each participant an individualized anonymous identifier. The project protocol was 
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submitted and approved by the Arizona State University Institutional Review Board to ensure 
protection.     
Procedure 
Once the participants were identified, the primary researcher had an initial meeting with 
the participant to explain mindfulness, the purpose of the study, obtain consents, and provide 
written and electronic resources to aid in completion of the study. The primary research collected 
self-reported questionnaires to obtain baseline scores of depression, anxiety, and mindfulness. 
Participants were informed of another set of scores to be taken at 30 days and 60 days after 
intervention. A workbook explaining mindfulness was provided to the participants along with a 
self-tracking log. The intervention consisted of listening to a 5-8 minute audio clips of 
mindfulness meditation focusing on guided exercises such as deep breathing, mindful eating, and 
body scan. The instructional audio clips were led by two mindfulness instructors through an 
educational website – http://www.wild5meditations.com. The instructions for the intervention 
consisted of listening and participating in one mindfulness meditation daily. 
Measures 
The outcomes of interest for this project include depression, anxiety, and measurement of 
effectiveness of mindfulness. The measurement tool used to measure depression was the Patient 
Health Questionnaire-9 (PHQ-9) (Appendix N). The PHQ-9 is a nine question depression 
module taken from the full Patient Health Questionnaire. The PHQ-9 can be used to measure the 
severity of depression as well as monitor symptom changes or the effect of treatment over time. 
The PHQ-9 scores per question are from zero to three; with the overall total score ranging from 0 
to 27. Depression severity can be identified as minimal or none,  mild, moderate, moderate-
severe, and severe depression depending on the respective ranges, 0-4, 5-9, 10-14, 15-19, and 
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greater than 20. Interestingly, higher PHQ-9 scores are correlated with decreased functional 
status and increased symptom-related difficulties such as increased healthcare utilization and 
sick days. The PHQ-9 has a sensitivity of 88% and specificity of 88% in detecting major 
depressive disorder in scores greater than 10 (Kroenke, Spitzer, & Williams, 2001). The PHQ-9 
is a reliable and valid measurement of depression severity. The validity and reliability of the 
construct, coupled with brevity and ease of use make this an ideal tool to use in this project.  
 The measurement tool selected to measure anxiety was the Generalized Anxiety Disorder 
7-item scale (GAD-7) (Appendix O). The GAD-7 is a 7 item self-report scale developed to 
assess symptoms of anxiety. It is a Likert-type scale similar to PHQ-9 – scoring by 0-3 over 
symptoms experienced in past 2 weeks. Designated cut off points for levels of anxiety are 0-4 for 
minimal, 5-9 for mild, 10-14 for moderate, and 15-21 for severe. Increasing scores are correlated 
with functional impairment. The GAD-7 has a sensitivity of 89% and specificity of 82% for 
detecting anxiety (Spitzer, Kroenke, Williams, & Lowe, 2006). In mood disorders, the GAD-7 
has been found to have a sensitivity of 79.5% and specificity of 44.7% in mood disorders (Rutter 
& Brown, 2017).   
The measurement tool selected to measure mindfulness was the Mindfulness Attention 
Awareness Scale (MAAS) (Appendix P). This is a 15 item survey focusing on present-centered 
attention-awareness in everyday experience. Different studies suggest a Cronbach’s alpha of 0.78 
to 0.92 and test-retest reliability of 0.81 (Park, Reilly-Spong, & Gross, 2013). This measurement 
completed prior to intervention, one month into intervention, and at conclusion of intervention 
can indicate how proficient the patients were at developing the mindfulness skill. The construct 
validity shows positive correlations with well-being, positive affect, and openness, while being 
negatively correlated with anxiety, stress, and rumination.  
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 The measurement tools for outcomes are strongly connected with the theoretical 
underpinning described by Pender’s Health Promotion Model. These measurement tools can not 
only measure current state of well-being or depression, but also can measure increased awareness 
of state of well-being, cognition, and can demonstrate their commitment to change through lower 
PHQ-9 and GAD-7 scores and higher MAAS scores.  
 Data analysis was completed using SPSS v. 23. Descriptive statistics were used to 
describe the sample and outcome variables. Mean scores before and after intervention were 
compared utilizing Paired Sample t Test. 
 The proposed budget for this project was only the cost of printing educational booklet 
and tracking sheets – which was 10 sheets per participant. 
Project Results 
Descriptive statistics were used to describe the sample and outcome variables (Appendix 
Q). The sample size at the beginning of the study was 35. The number of participants who 
completed the 30 day baseline scores was only 17. The number of participants completing the 
intended 60 days was only 3. There was an 82% attrition rate. Due to this attrition rate, the 
primary endpoint of the study was changed to the 30 day mark post intervention. The final 
sample (n = 17) consisted of all females. A combined age range of 76.8% was between 18 and 34 
years old. Of this group 35.3% were 18-24 and 41.2% were in the 25 to 34 year old range. The 
ethnicity was 41.2% White, 41.2% Hispanic, and 11.8% Black. The education level varied, but 
the most frequent occurrence was some college, obtained by 9 out of 17 participants or 52.9%.  
The paired-samples t test was used to compare the mean baseline scores of the PHQ-9, 
GAD-7, and MAAS to the mean scores 30 days after the intervention (Appendix R). The mean 
on the PHQ-9 at baseline was 16.7 (sd = 4.73), and the mean at 30 days was 12.9 (sd = 4.96), 
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95% CI [1.17, 6.48]. A significant increase from baseline to the 30 day period was found (t(16) = 
3.054, p= .008). This improved scores by an average of approximately 4 points. The mean on the 
GAD-7 at baseline was 16.9 (sd = 2.63), and the mean at 30 days was 11.4 (sd = 4.50), 95% CI 
[2.94, 8.11]. A significant increase from baseline to the 30 day period was found (t(16) = 4.536, 
p < .001). This decreased anxiety scores by an average of approximately 5 points. The mean 
score of the MAAS at baseline was 40.1 (sd = 10.64), and the mean at 30 days was 48.4.4 (sd = 
11.33), 95% CI [-11.03, -5.56]. There is strong evidence (t(16) = - 6.437), p < .001) that the 
mindfulness intervention improves mindfulness.  
The pre-post effect size for the PHQ-9 was d = 0.74 signifying a medium effect. The 
effect size for the GAD-7 was d = 1.10, while the effect size for MAAS was d = 1.56, both 
signifying large effect. Refer to Figure 1 and Figure 2 to see graphical results of the 
improvement in scores.    
Impact of Project 
The results are positive for statistical and clinical significance in reducing depression and 
anxiety in adults diagnosed with depression and/or anxiety. The mindfulness intervention was 
statistically significant in decreasing mean scores of depression and anxiety respectively. 
Clinically, the difference in depression and anxiety mean scores is sufficient to signify a decrease 
from moderate-severe to moderate levels of depression and anxiety. The mindfulness 
intervention further demonstrated that mindfulness increased with practice.  
Discussion  
 The aim of this project was to evaluate the effectiveness of a self-directed daily 
mindfulness intervention on depression and anxiety. The results were relevant in decreasing both 
depression and anxiety. This is important as it provides evidence that a quick, self-directed 
EFFECTS OF MINDFULNESS ON DEPRESSION AND ANXIETY 19  
 
mindfulness intervention is beneficial as an adjunct to traditional pharmacological treatment. The 
results resemble the research indicating that mindfulness-based interventions are effective in 
decreasing depression and anxiety.  
 The data showed that the mindfulness score increased with practice. This can lead to the 
conclusion that mindfulness is a skill that can be learned. The use of this skill can be further 
beneficial as, in theory, the person exposed to the mindfulness intervention can demonstrate 
increased proficiency and share this intervention with family or friends suffering from depression 
or anxiety. The fact that this intervention was cost-effective improves the ability to be shared and 
practiced. This can result in improved outcomes not only for the individual, but also for the 
community. The intervention provided a sense of empowerment, where the individual was active 
in their recovery in addition to the passive action of receiving medication. The information can 
be generalized to state that the improvement of depression and anxiety can also result in 
decreased utilization of the healthcare system. Empowering the population to improve their 
wellness can result in better health outcomes for the individual and population, as well as benefit 
the economic burden of these diseases.  
 The sustainability of this intervention is very feasible. As discussed, this intervention was 
cost-effective, costing only the sheets of paper to be distributed to participants. This intervention 
implemented the use of technology and innovation, which are supported by the host 
organization. Some patients reported that the technology piece added mobility and increased 
access to interventions helpful toward their health. There were even some who stated that the 
intervention was used not only once daily according to project protocol, but on an as needed 
basis, particularly to dissuade anxious feelings or negative thinking. Another contributing factor 
favoring sustainability is the relatively quick use of measurement tools such as the PHQ-9, 
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GAD-7, and MAAS. These tools can be easily implemented without taking much time out of a 
psychiatric assessment and can be supported by evidence-based practice to utilize measurable 
tools in providing effective healthcare. Healthcare payment and insurance requirements can also 
be satisfied by providing measurable outcomes which can point toward improved quality of care. 
As our healthcare system moves toward value-based payment, this can not only improve quality 
of individual patient experience and health, but also result in an overall decrease in cost. 
Particularly as our healthcare system focuses on prevention, the use of this intervention can shift 
the focus towards working on improving wellness as opposed to treatment of symptoms.  
The strengths of this project included strong support from the clinical site and champions 
of change. The intervention was simple, implementable, and cost effective. The ability to provide 
an evidence-based intervention that is cost-efficient and shown to provide positive outcomes to 
leadership positions in the healthcare group can ensure appropriate support and implementation 
as an intervention. The intervention was an adjunct to pharmacotherapy resulting in little to no 
risk of potentially dangerous outcomes.  
 There are several limitations to the project. The most glaring limitation is the relatively 
small sample size. There was a high attrition rate, 82%, necessitating the movement of the 
primary endpoint from 60 days to 30 days. The attrition rate in most cases was due to a closure 
of services, meaning the patient did not follow up with the clinic or cancelled services. There 
were some who felt the audio clips were not what they expected. Conversely, there were some 
participants who withdrew due to feeling better and focusing on other activities and thus not 
practicing mindfulness. A significant limitation to data collection was the lack of adherence to a 
tracking log. The self-reporting log was unreliable. Many patients did not mark the days the 
intervention was completed and as such could only give an estimate of the amount of days that 
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the intervention was actually performed. A significant limitation is the lack of control group to 
directly assign improvement to the intervention. All participants were also being prescribed 
medications at the time of project. It is difficult to say with certainty that the improvement in 
depression and anxiety were solely the result of the mindfulness intervention. There was 
similarly insufficient information or screening for participants who may have been naïve to 
therapy or had past experience with mindfulness. Lastly, the information cannot be generalized 
to other populations. The sample consisted of adults with an established diagnosis of depression 
and anxiety, and as such applicability to the general population would not apply.  
Conclusion 
The results demonstrated the value of utilizing mindfulness as a cost-effective therapy in 
addition to or potentially separate from pharmacological treatment to decrease symptoms of 
depression and anxiety, as well as improve mindfulness. The ease of use demonstrated the value 
of mindfulness and self-directed skills aimed at improving wellness, reducing depression and 
anxiety which will result in the improvement of individual, economic, healthcare system, and 
community health. Further study research is warranted to investigate the use of mindfulness for 
other mental health disorders or populations. An important area of interest would also include 
following the participants for a longer period of time to establish rates of relapse and the time 
between each episode. In conclusion, the mindfulness intervention was effective and provides an 
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Mean effect size -
0.76, participants in 
MBCT reported 
depressive 
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standard deviation 
less than those IV3. 
p = 0.01 





trials - meta-analysis 
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Mean effect size is -
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MBCT produced large 
and medium size 
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and useful as 
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larger in RCT than 
in naturalistic 
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higher in naturalistic 
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Different countries of 
samples, may increase 
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risk 
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Year 2006 2012 2005 2015 2012 2016 2015 2016 2016 2016 2013 2015 2013 
LOE I II II III I II II I II II II II I 
Design SR RCT RCT NRCT RCT RCT RCT RCT RCT RCT RCT RCT SR 




HAMD-D  X X X X X X X     B 
BDI  X     X     X X 
MADRS             X 
QIDSR    X          
SWL            X  
ROM          X    
BSI         X X    
WSQ          X    
IDS-C      X        
WHOQOL      X X       
GSI         X     








CBT X  X  X   X X X   X 
MBCT    X  X       X 
AD X  X X X X X  X  X   
CBT + AD  X        X X X  
MBCT + 
AD 
 X     X    X X  









↓ DEP X X X  X X X ↓↓↓ ↓↓ X  X ↓ 
↓ Recur  X X ↓   X   X  X ↓ 
↓ Relapse  X X  X X X X X X X X ↓ 
↑ QOL   ↑↑↑    ↑↑ ↑   ↑↑↑  ↑↑↑  






































































 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 18-24 6 35.3 35.3 35.3 
25-34 7 41.2 41.2 76.5 
35-44 4 23.5 23.5 100.0 
Total 17 100.0 100.0  
 
Ethnicity 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid White 7 41.2 41.2 41.2 
Hispanic or Latino 7 41.2 41.2 82.4 
Black or African American 2 11.8 11.8 94.1 
Hawaiian/Pacific Islander 1 5.9 5.9 100.0 
Total 17 100.0 100.0  
 
Gender 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Female 17 100.0 100.0 100.0 
 
School 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid No 11 64.7 64.7 64.7 
Yes 6 35.3 35.3 100.0 
Total 17 100.0 100.0  
 
 
Highest Level Completed 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
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Valid Some high school, No 
Diploma 
4 23.5 23.5 23.5 
High School Graduate/GED 1 5.9 5.9 29.4 
Some College 9 52.9 52.9 82.4 
Associate's Degree 2 11.8 11.8 94.1 
Bachelor's Degree 1 5.9 5.9 100.0 




 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Self-Employed 1 5.9 5.9 5.9 
Employed Full Time 4 23.5 23.5 29.4 
Employed Part Time 3 17.6 17.6 47.1 
Homemaker 5 29.4 29.4 76.5 
Student 4 23.5 23.5 100.0 




 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 0 - 24,9999 13 76.5 76.5 76.5 
25,000 - 49,999 4 23.5 23.5 100.0 






















































Paired Samples Statistics 
 Mean N Std. Deviation Std. Error Mean 
Pair 1 PHQ-9 Baseline 16.7059 17 4.72711 1.14649 
PHQ-9 30 days 12.8824 17 4.96088 1.20319 
Pair 2 GAD-7 Baseline 16.9412 17 2.63322 .63865 
GAD-7 30 days 11.4118 17 4.50082 1.09161 
Pair 3 MAAS Baseline 40.0588 17 10.64466 2.58171 
MAAS 30 days 48.3529 17 11.32994 2.74792 











































Figure 1. Mean scores for depression and anxiety both before and after the intervention. Both 


































Figure 2. Mean scores for mindfulness before and after the intervention. Mindfulness scores 



































Figure 3. Box and whisker plot demonstrating improved mean after intervention for depression. 




Figure 4. Box and whisker plot for anxiety scores demonstrating significant reduction in GAD-7 
scores. Post intervention, majority of scores are at or below 12, with the lowest score being a 4. 
Range from 4 to 19. 
 




Figure 5. Box and whisker plot for mindfulness scores demonstrating significant improvement in 
MAAS scores. Post intervention, majority of scores are above 50, with the range from 31 to 63. 
Pre-intervention, the range was 22 to 58.  
 
